Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.
- Published In:
- Journal of gastrointestinal oncology, 14(3), 1204-1217 (2023)
- Authors:
- Prétot, Dominique, Engel-Bicik, Ivette, Kenkel, David, Kaufmann, Philipp A, Treyer, Valerie, Siebenhüner, Alexander R
- Database ID:
- RPEP-07289
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07289APA
Prétot, Dominique; Engel-Bicik, Ivette; Kenkel, David; Kaufmann, Philipp A; Treyer, Valerie; Siebenhüner, Alexander R. (2023). Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.. Journal of gastrointestinal oncology, 14(3), 1204-1217. https://doi.org/10.21037/jgo-22-874
MLA
Prétot, Dominique, et al. "Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.." Journal of gastrointestinal oncology, 2023. https://doi.org/10.21037/jgo-22-874
RethinkPeptides
RethinkPeptides Research Database. "Outcome analysis in patients with metastatic gastroenteropan..." RPEP-07289. Retrieved from https://rethinkpeptides.com/research/pretot-2023-outcome-analysis-in-patients
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.